SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-122417
Filing Date
2023-11-30
Accepted
2023-11-30 16:05:37
Documents
4
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2329475-1_def14a.htm DEF 14A 478237
2 GRAPHIC lg_petros-4clr.jpg GRAPHIC 13162
3 GRAPHIC px_23proxy1pg01-bw.jpg GRAPHIC 222496
4 GRAPHIC px_23proxy1pg02-bw.jpg GRAPHIC 256281
  Complete submission text file 0001104659-23-122417.txt   1098426
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 231455725
SIC: 2834 Pharmaceutical Preparations